|
Article Excerpt Business Editors/Health/Medical Writers
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 19, 2003
Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.05 per issued and outstanding share of its Common Stock payable on October 31, 2003, to stockholders of record at the close of business on October 1, 2003.
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological, pediatric and podiatric conditions. Medicis has leading prescription products in a number of therapeutic categories, including acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, rosacea, seborrheic dermatitis and skin and...
|
|

More articles from Business Wire
ADVISORY/Meet This Year's Grand Marshal - David Cassidy; Cingular Wire..., September 19, 2003 Denver Gold Group Announces Web Casting of Its Denver Gold Forum 2003., September 19, 2003 JLM Couture, Inc. Reports Third Quarter Results., September 19, 2003 A.M. Best Places Rating of Goshawk Reinsurance Limited Under Review., September 19, 2003 The Gabelli Utility Trust Extends Its Rights Offering to September 25,..., September 19, 2003
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|